Filing Flows › Comparisons › MRVI vs ORGO
Maravai Lifesciences Holdings vs Organogenesis Holdings: MRVI and ORGO compared
Maravai Lifesciences Holdings is the larger company: $45.9M of revenue in its latest quarter (Q3 2026) against $45.5M for Organogenesis Holdings (Q3 2026). Maravai Lifesciences Holdings is growing faster (+10% against -70% a year earlier). Maravai Lifesciences Holdings is more profitable, with an operating margin of -45.0% against -64.9%.
Where the money goes: MRVI and ORGO
Maravai Lifesciences Holdings (MRVI) · Q3 2026
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Organogenesis Holdings (ORGO) · Q3 2026
Organogenesis Holdings, Q3 2026: revenue $45.5M (-70% year over year), operating margin -64.9%, net loss $29.6M, operating cash flow −$18.6M. The chart follows the revenue to costs, profit and cash.
| Maravai Lifesciences Holdings (MRVI) | Organogenesis Holdings (ORGO) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $45.9M | $45.5M |
| Revenue growth, Y/Y | +10% | -70% |
| Operating margin | -45.0% | -64.9% |
| Net earnings | −$24.0M | −$29.6M |
| Net margin | -52.3% | -65.2% |
| Operating cash flow | $5.0M | −$18.6M |
| Free cash flow | $4.5M | — |
Where the revenue comes from
Maravai Lifesciences Holdings
- TriLink: $28.4M (62%)
- Cygnus: $17.5M (38%)
Questions
Which is bigger, Maravai Lifesciences Holdings or Organogenesis Holdings?
Maravai Lifesciences Holdings is the larger company: $45.9M of revenue in its latest quarter (Q3 2026) against $45.5M for Organogenesis Holdings (Q3 2026).
Is Maravai Lifesciences Holdings or Organogenesis Holdings growing faster?
Maravai Lifesciences Holdings is growing faster (+10% against -70% a year earlier).
Which is more profitable, Maravai Lifesciences Holdings or Organogenesis Holdings?
Maravai Lifesciences Holdings is more profitable, with an operating margin of -45.0% against -64.9%.
More: Maravai Lifesciences Holdings earnings · how Maravai Lifesciences Holdings makes money · Organogenesis Holdings earnings · how Organogenesis Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.